These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 17328247

  • 1. Effect of atorvastatin on the pharmacokinetics of diltiazem and its main metabolite, desacetyldiltiazem, in rats.
    Hong SP, Chang KS, Choi DH, Choi JS.
    Arch Pharm Res; 2007 Jan; 30(1):90-5. PubMed ID: 17328247
    [Abstract] [Full Text] [Related]

  • 2. Enhanced oral exposure of diltiazem by the concomitant use of naringin in rats.
    Choi JS, Han HK.
    Int J Pharm; 2005 Nov 23; 305(1-2):122-8. PubMed ID: 16226412
    [Abstract] [Full Text] [Related]

  • 3. Effects of epigallocatechin gallate on the bioavailability and pharmacokinetics of diltiazem in rats.
    Li C, Choi JS.
    Pharmazie; 2008 Nov 23; 63(11):815-8. PubMed ID: 19069242
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Effect of atorvastatin on the intravenous and oral pharmacokinetics of verapamil in rats.
    Choi DH, Chang KS, Hong SP, Choi JS, Han HK.
    Biopharm Drug Dispos; 2008 Jan 23; 29(1):45-50. PubMed ID: 17941000
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Effect of hesperidin on the oral pharmacokinetics of diltiazem and its main metabolite, desacetyldiltiazem, in rats.
    Cho YA, Choi DH, Choi JS.
    J Pharm Pharmacol; 2009 Jun 23; 61(6):825-9. PubMed ID: 19505375
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Pharmacokinetic interaction between diltiazem and morin, a flavonoid, in rats.
    Choi JS, Han HK.
    Pharmacol Res; 2005 Nov 23; 52(5):386-91. PubMed ID: 16002304
    [Abstract] [Full Text] [Related]

  • 12. Simvastatin and atorvastatin enhance hypotensive effect of diltiazem in rats.
    Marumo H, Satoh K, Yamamoto A, Kaneta S, Ichihara K.
    Yakugaku Zasshi; 2001 Oct 23; 121(10):761-4. PubMed ID: 11676178
    [Abstract] [Full Text] [Related]

  • 13. The influence of cimetidine on the pharmacokinetics of diltiazem and its main metabolite in rabbits.
    Choi JS, Burm JP.
    Arch Pharm Res; 2004 Feb 23; 27(2):254-8. PubMed ID: 15022730
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effects of HMG-CoA reductase inhibitors on the pharmacokinetics of losartan and its main metabolite EXP-3174 in rats: possible role of CYP3A4 and P-gp inhibition by HMG-CoA reductase inhibitors.
    Yang SH, Choi JS, Choi DH.
    Pharmacology; 2011 Feb 23; 88(1-2):1-9. PubMed ID: 21709429
    [Abstract] [Full Text] [Related]

  • 16. Pharmacokinetics of the calcium-channel blocker diltiazem after a single intravenous dose in horses.
    Schwarzwald CC, Sams RA, Bonagura JD.
    J Vet Pharmacol Ther; 2006 Jun 23; 29(3):165-71. PubMed ID: 16669860
    [Abstract] [Full Text] [Related]

  • 17. Effects of lovastatin on the pharmacokinetics of verapamil and its active metabolite, norverapamil in rats: possible role of P-glycoprotein inhibition by lovastatin.
    Hong SP, Chang KS, Koh YY, Choi DH, Choi JS.
    Arch Pharm Res; 2009 Oct 23; 32(10):1447-52. PubMed ID: 19898809
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Pharmacokinetic and pharmacodynamic assessments of HMG-CoA reductase inhibitors when coadministered with everolimus.
    Kovarik JM, Hartmann S, Hubert M, Berthier S, Schneider W, Rosenkranz B, Rordorf C.
    J Clin Pharmacol; 2002 Feb 23; 42(2):222-8. PubMed ID: 11831546
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.